1.
J Pediatric Infect Dis Soc
; 9(3): 386-389, 2020 Jul 13.
Article
in English
| MEDLINE
| ID: mdl-31310312
ABSTRACT
We assessed the safety and efficacy of a generic form of ledipasvir-sofosbuvir for the treatment of hepatitis C virus infection in Egyptian adolescents and compared the results with those of treatment with the brand-named form. The generic form resulted in a high response rate, significant improvement in liver function, and mild adverse effects. These results are comparable with those of the brand form at a reduced price.